Press Release – New York, NY – November 17, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented an institutional investor in the recently announced financing arrangements for up to $20 million of Ensysce Biosciences, Inc. (NASDAQ: ENSC), a pioneer of novel solutions for severe pain with built-in abuse and overdose protection.
The SRFC team was led by partner Ross Carmel, with associate Soumya Cheedi.